Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Regulatory
Fierce Healthcare
CMS delays Part D GLP-1 model amid skepticism from insurers
The Trump administration is delaying a voluntary model that aimed to expand access to GLP-1s in Part D after pushback from insurers.
Paige Minemyer
Apr 22, 2026 12:00pm
Fierce Healthcare
Bill to force payers to apply DTC drug purchases to deductibles
Apr 14, 2026 2:23pm
Fierce Healthcare
States' lawsuit against RFK Jr.'s HHS overhaul moves forward
Apr 9, 2026 7:30am
Fierce Healthcare
CMS extends application deadline for Medicaid drug pricing model
Mar 2, 2026 3:00pm
Fierce Healthcare
Trump administration restarts its efforts to pilot 340B rebates
Feb 13, 2026 1:00pm
Fierce Healthcare
HHS agrees to toss 340B Rebate Model Pilot Program
Feb 6, 2026 11:00am